SALIX PHARMACEUTICALS LTD Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31)
SALIX PHARMACEUTICALS LTD reported Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) of $181.01 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Income Statement › Other Income
us-gaap:SegmentReportingInformationRevenue · last filed 2012-08-09
- SALIX PHARMACEUTICALS LTD segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $181.01M, a 35.93% increase year-over-year.
- SALIX PHARMACEUTICALS LTD segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $171.13M, a 61.60% increase year-over-year.
- SALIX PHARMACEUTICALS LTD segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2011-09-30 was $146.25M, a 81.39% increase year-over-year.
- SALIX PHARMACEUTICALS LTD segment reporting information, revenue for reportable segment (deprecated 2013-01-31) for the quarter ending 2011-06-30 was $133.16M, a 42.00% increase year-over-year.
| Period end | Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) 3 month | Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) 6 month | Segment Reporting Information, Revenue for Reportable Segment (Deprecated 2013-01-31) 9 month |
|---|---|---|---|
| 2012-06-30 | $181.01M 10-Q · filed 2012-08-09 | $352.14M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $171.13M 10-Q · filed 2012-05-08 | ||
| 2011-09-30 | $146.25M 10-Q · filed 2011-11-09 | $279.41M derived: sum of 2 quarters · filed 2012-08-09 | $385.31M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $133.16M 10-Q · filed 2012-08-09 | $239.06M 10-Q · filed 2012-08-09 | |
| 2011-03-31 | $105.90M 10-Q · filed 2012-05-08 | ||
| 2010-09-30 | $80.63M 10-Q · filed 2011-11-09 | $174.40M derived: sum of 2 quarters · filed 2011-11-09 | $218.47M 10-Q · filed 2011-11-09 |
| 2010-06-30 | $93.77M 10-Q · filed 2011-08-09 | $137.85M 10-Q · filed 2011-08-09 |